STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

RZLT Form 3: Chief Commercial Officer Discloses 12,340 Common Shares

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Rezolute, Inc. (RZLT) Form 3 filed for Sunil Ratilal Karnawat reports initial beneficial ownership disclosures for an officer serving as Chief Commercial Officer. The filing shows 2,442 common shares held directly, plus 8,000 common shares held indirectly in an IRA and 1,898 common shares held indirectly in a Health Savings Account, for a total of 12,340 shares reported. The filing is signed and dated by the reporting person.

Positive

  • Initial beneficial ownership disclosed with direct and indirect holdings clearly itemized
  • Form appears signed and dated, indicating timely completion of reporting obligations

Negative

  • None.

Insights

TL;DR: Routine initial Form 3 disclosing modest ownership by a company officer; no derivatives or material transactions reported.

The Form 3 is an initial Section 16 disclosure that lists direct and indirect holdings only: 2,442 shares directly, 8,000 shares in an IRA and 1,898 shares in an HSA, totaling 12,340 common shares. There are no derivative securities reported and no amendment indicated. This filing fulfills reporting obligations but provides no new operational or financial metrics for valuation.

TL;DR: Compliance-focused disclosure by an officer; useful for insider ownership tracking but not material by itself.

The disclosure identifies the reporting person as Chief Commercial Officer and a director-level officer who filed individually. Ownership is split between direct and two types of indirect accounts (IRA and HSA). The form appears complete with signature and date, meeting basic governance transparency requirements. No red flags or material changes are shown.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Karnawat Sunil Ratilal

(Last) (First) (Middle)
C/O REZOLUTE, INC.
275 SHORELINE DRIVE, SUITE 500

(Street)
REDWOOD CITY CA 94065

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/18/2025
3. Issuer Name and Ticker or Trading Symbol
Rezolute, Inc. [ RZLT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Commercial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 2,442 D
Common Shares 8,000 I Held in IRA
Common Shares 1,898 I Held in Health Savings Account
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Sunil Patilal Karnawat 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 3 for RZLT disclose about Sunil Karnawat's holdings?

The filing reports 2,442 common shares directly owned, 8,000 common shares held in an IRA, and 1,898 common shares held in a Health Savings Account, totaling 12,340 shares.

What is Sunil Karnawat's role at Rezolute, Inc. according to the Form 3?

The form identifies the reporting person as an officer with the title Chief Commercial Officer and indicates director-level relationship.

Are there any derivative securities reported on this Form 3 for RZLT?

No. Table II for derivative securities lists no exercisable or expiring derivative instruments in this filing.

When was the event requiring this Form 3 reported?

The Date of Event Requiring Statement is listed as 08/18/2025 and the form is signed on 08/27/2025.

Was the Form 3 filed jointly or by one reporting person?

The filing indicates Form filed by One Reporting Person (individual filing).
Rezolute Inc

NASDAQ:RZLT

RZLT Rankings

RZLT Latest News

RZLT Latest SEC Filings

RZLT Stock Data

886.48M
82.97M
9.68%
90.03%
8.53%
Biotechnology
Pharmaceutical Preparations
Link
United States
REDWOOD CITY